Rankings
▼
Calendar
TMCI
Treace Medical Concepts, Inc.
$104M
Q4 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$69M
+10.4% YoY
Gross Profit
$55M
80.7% margin
Operating Income
-$204,000
-0.3% margin
Net Income
-$501,000
-0.7% margin
EPS (Diluted)
$-0.01
QoQ Revenue Growth
+52.4%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$7M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$217M
Total Liabilities
$104M
Stockholders' Equity
$113M
Cash & Equivalents
$11M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$69M
$62M
+10.4%
Gross Profit
$55M
$51M
+9.3%
Operating Income
-$204,000
-$7M
+97.0%
Net Income
-$501,000
-$6M
+92.0%
← FY 2024
All Quarters
Q1 2025 →
TMCI Q4 2024 Earnings — Treace Medical Concepts, Inc. Revenue & Financial Results | Market Cap Arena